CNCE
Concert Pharmaceuticals Inc
Price:  
8.37 
USD
Volume:  
10,724,200
United States | Biotechnology
No data available for this ticker

CNCE Probability of Bankruptcy

The Probability of Bankruptcy of Concert Pharmaceuticals Inc (CNCE) is 0% . This number represents the probability that CNCE will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating CNCE's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

CNCE - Historical Solvency Measures

Drag here to set row groups
Drag here to set column labels
to of Page of

CNCE - ESG ratings

ESG ratings are directly linked to the cost of capital and CNCE's ability to raise funding, both of which can significantly affect the probability of Concert Pharmaceuticals Inc going bankrupt.

ESG Score

0

Environment Score

0

Social Score

0

Governance Score

0
Returns
Historical Returns (5 day)16.46%
Historical Returns (MTD)41.78%
Historical Returns (YTD)41.78%
Historical Returns (13 week)54.77%
Historical Returns (26 week)84.82%
Historical Returns (52 week)170.59%
Efficiency
Asset Turnover0
Receiveable Turnover0.04
Gross Margin-
Operating Margin-
Pretax Margin-
Net Margin-
Return on Asset (ROA)-102.16
Return on Equity (ROE)-145.86
Return on Investments (ROI)-145.86
Price Metrics
Market Cap (M)401.9
Enterprise Value (M)306.8
52 Week High8.34
52 Week Low2.59
Beta0.41
Average Volume (10 day)7.11
Average Volume (3 month)30.48
Price / Earnings (P/E)-
Price / Sales (P/S)9,570.2
Earnings
EPS-3.95
Revenue CAGR (5 year)176.94%
Risk
Current Ratio9.03
Quick Ratio8.69